KDP Prices $2B Stock Sale at $34.50, a Discount to Thursday's Close
KDP sits 41% above its 52-week low of $24.875 on elevated volume (2.8× avg).
Summary
KDP closed its stock offering on November 16, 2026, selling all 66,666,667 shares — the 57,971,015 firm shares plus the full 8,695,652 option shares — at $34.50 apiece, for about $2.25 billion of net proceeds after the underwriting discount. The public offering price was about 1.5% below the $35.04 last price, and the underwriters, led by Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC, bought at $33.72375 per share. Proceeds go straight to debt: the company plans to repay or repurchase about $2.0 billion of borrowings, including its delayed draw term loan, commercial paper and senior unsecured notes, with any option proceeds also going to debt reduction. The point is to cut leverage ahead of the early-2027 split into Beverage Co. and Global Coffee Co. and protect the investment-grade ratings of both. The deal carries 60-day lock-ups on the company and on the officers and directors listed on Schedule III, with limited exceptions including sales of up to 25,000 shares and no more than one Section 16 filing during the period, and closing was conditioned on no rating downgrade or notice of a potential one. The dilution is real but the use of proceeds is deleveraging, not spending — the discount is modest and the deal was already in the market.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — KDP closed the offering on November 16, 2026, selling all 8,695,652 option shares for about $2.25 billion of net proceeds to repay or repurchase debt.
- Option Exercise — Underwriters exercised the option in full: 8,695,652 additional shares sold, for a total offering of 66,666,667 shares. Net proceeds were approximately $2.25 billion after the underwriting discount, intended to further repay or repurchase outstanding debt.
- Pricing Terms — Public offering price was $34.50 per share, with $33.72375 per share paid to underwriters. The offering commenced as $2.0 billion of common stock with a 30-day option to purchase up to an additional $300 million of shares at the same price per share.
- Use of Proceeds — Net proceeds are intended to repay or repurchase outstanding debt, which may include borrowings under the Delayed Draw Term Loan Agreement, commercial paper notes and senior unsecured notes.
- Lock-Ups
- Company agreed to a 60-day lock-up covering the officers and directors listed on Schedule III.
- Lock-up bars officers/directors from offering, selling, pledging, granting options or otherwise transferring Common Stock for 60 days after the Prospectus date.
- Lock-up exceptions include transfers or sales of up to, but not more than, 25,000 shares, with no more than one Section 16 filing during the Lock-Up Period.
- Company agreed not to offer, sell, pledge or dispose of stock for 60 days after the Prospectus date without consent, subject to customary exceptions.
- Company lock-up: 60 days after the date of the Prospectus; carve-out for acquisitions, joint ventures, commercial relationships or strategic transactions up to 5% of total capital stock outstanding immediately following the offering.
- Company lock-up exceptions: Series A Convertible Perpetual Preferred Stock registration rights obligations, equity awards, Rule 10b5-1 plan establishment, and repurchases under existing agreements or rights of first refusal.
- Officer/director lock-up exceptions: open-market purchases, gifts, estate planning transfers, Rule 10b5-1 plans, net settlement, divorce, tender offers.
- Underwriters — Goldman Sachs & Co. LLC took 28,985,508 firm shares and Morgan Stanley & Co. LLC took 28,985,507 firm shares under an Underwriting Agreement dated November 12, 2026.
- Closing Conditions — Closing is conditioned on no downgrade or notice of potential downgrade in the rating of Company securities, no material adverse change, no trading suspension or banking moratorium, and Deloitte US and Deloitte Netherlands comfort letters.
- Legal and Expenses — Underwriter counsel fees for Blue Sky and FINRA review are reimbursable, capped at $25,000 in the aggregate. The legal opinion covers 66,666,667 shares, and the agreement may be terminated if unpurchased shares exceed one-eleventh of total firm and optional securities.
- Offering Documents — An electronic roadshow dated November 11, 2026 is an Issuer Free Writing Prospectus not included in the Pricing Disclosure Package.
All 25 details
- Purchase price per share to underwriters $33.72375; public offering price $34.50 per share.
- Company agreed to a 60-day lock-up covering the officers and directors listed on Schedule III.
- Lock-up bars officers/directors from offering, selling, pledging, granting options or otherwise transferring Common Stock for 60 days after the Prospectus date.
- Lock-up exceptions include transfers or sales of up to, but not more than, 25,000 shares, with no more than one Section 16 filing during the Lock-Up Period.
- Underwriters Goldman Sachs & Co. LLC (28,985,508 firm shares) and Morgan Stanley & Co. LLC (28,985,507 firm shares).
- Company agreed not to offer, sell, pledge or dispose of stock for 60 days after the Prospectus date without consent, subject to customary exceptions.
- Underwriter counsel fees for Blue Sky and FINRA review reimbursable, capped at $25,000 in the aggregate.
- Legal opinion covers 66,666,667 shares, including option shares, validly issued, fully paid and non-assessable.
- Underwriting Agreement dated November 12, 2026 among Keurig Dr Pepper Inc., Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC.
- Net proceeds intended to repay or repurchase outstanding debt, which may include borrowings under its Delayed Draw Term Loan Agreement, commercial paper notes and senior unsecured notes.
- To the extent the underwriters exercise their option to purchase additional shares, additional net proceeds intended to further repay or repurchase outstanding debt.
- Offering commenced as $2.0 billion of shares of common stock; 30-day option to purchase up to an additional $300 million of shares at the same price per share.
- Underwriters exercised option in full: 8,695,652 additional shares sold; total offering 66,666,667 shares.
- Net proceeds approximately $2.25 billion after deducting the underwriting discount, without deducting other offering fees and expenses.
- Company lock-up: 60 days after the date of the Prospectus; carve-out for acquisitions, joint ventures, commercial relationships or strategic transactions up to 5% of total capital stock outstanding immediately following the offering.
- Company lock-up exceptions: Series A Convertible Perpetual Preferred Stock registration rights obligations, equity awards, Rule 10b5-1 plan establishment, and repurchases under existing agreements or rights of first refusal.
- Officer/director lock-up exceptions: open-market purchases, gifts, estate planning transfers, Rule 10b5-1 plans, net settlement, divorce, tender offers.
- Closing condition: no downgrade, and no notice of potential downgrade, in rating of Company securities.
- Closing conditioned on no material adverse change and no suspension of trading or banking moratorium.
- Closing conditioned on Deloitte US and Deloitte Netherlands comfort letters with cut-off date not earlier than the date of the Underwriting Agreement.
- Underwriters' counsel: Simpson Thacher & Bartlett LLP, 425 Lexington Avenue, New York, New York 10017; Company counsel: Paul, Weiss, Rifkind, Wharton & Garrison LLP.
- If unpurchased shares exceed one-eleventh of the total firm and optional securities, the Underwriting Agreement may be terminated.
- Company reimburses underwriters' out-of-pocket expenses if securities are not delivered for reasons other than default.
- Electronic roadshow dated November 11, 2026 is an Issuer Free Writing Prospectus not included in the Pricing Disclosure Package.
- Pricing Disclosure Package: public offering price $34.50 per share; 57,971,015 shares; optional securities up to 8,695,652.
At the time of this announcement, KDP was trading at $35.04 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $48.2B. The 52-week trading range was $24.88 to $38.29. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: PR Newswire.